Prospect News: News for BioScrip, Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with B > Issuers starting with B, HY only > All stories on BioScrip, Inc. > Stories on BioScrip, Inc., HY only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

BioScrip, Inc.

5/15/2019	HY	Moody’s cuts Novolex
5/15/2019	HY	Moody’s cuts Novolex
5/15/2019	BKDDHY	Moody’s lifts BioScrip, rates loan B2
5/15/2019	BKHY	S&P rates BioScrip loan B-
3/18/2019	BKDDHY	Moody’s might lift BioScrip
8/10/2018	BKDDHY	S&P upgrades BioScrip
8/7/2018	BWDDHY	BioScrip ‘confident’ it will record $75 million of EBITDA for 2018
7/30/2018	BKDDHY	Moody’s upgrades BioScrip
8/1/2017	BKDDHY	Moody’s ups BioScrip PDR, rates notes
7/5/2017	BKDDHY	S&P rates BioScrip notes CCC+, CC
6/29/2017	HYIG	Market Commentary: Bioscrip plans $310 billion facilities; Jones Lang wraps €350 million
1/23/2017	HY	Market Commentary: Bleeding goes on for Neiman Marcus, declines steep; Avaya up; healthcare, pharma mixed
1/10/2017	BKDDHY	S&P assigns CCC+ to BioScrip facility
12/16/2016	BKDDHY	S&P could lower BioScrip
11/10/2016	BKDDHY	S&P downgrades BioScrip
9/19/2016	BKCVDDEMHY	S&P global speculative-grade default rate increases to 3.88% in July
8/15/2016	BKDDHY	S&P: BioScrip view now stable
3/3/2016	BKDDHY	Moody’s cuts BioScrip, loans, notes
8/11/2015	BKDDHY	S&P cuts BioScrip, loan, notes
6/4/2015	BKDDHY	S&P lowers BioScrip view to negative
3/5/2015	BKDDHY	Moody’s drops BioScrip, loans
8/7/2014	BKBWHY	BioScrip reports increased cash, debt of $419 million at end of Q2
5/30/2014	BKDDHY	S&P downgrades BioScrip
2/10/2014	HY	Market Commentary: B Communications, Meritor deals price, trade up; overall market seen firm, Caesars paper busy
2/7/2014	HY	Market Commentary: Lansing Trade five-year deal caps $6.6 billion primary week; most recent deals firm smartly
2/6/2014	HY	BioScrip talks $200 million seven-year notes to yield 8 7/8%-9%; books close 1 p.m. ET Thursday
2/6/2014	HY	New Issue: BioScrip sells $200 million seven-year notes at par to yield 8 7/8%
2/6/2014	HY	Market Commentary: Oshkosh, BioScrip price; new Micron, American Greetings bonds firm; funds plunge $972 million
2/3/2014	HY	Market Commentary: BioScrip slates, but no pricings as stocks, weather chill primary; market anticipates Chrysler
2/3/2014	HY	BioScrip starts roadshow for $200 million seven-year notes; pricing late this week
7/19/2013	HYLM	BioScrip intends to redeem all $225 million of its 101/4% senior notes
7/9/2013	HYLM	BioScrip further extends expiration of tender offer for 101/4% notes
6/19/2013	BKHY	Moody's gives BioScrip loan B2
6/17/2013	HYLM	BioScrip gets tenders for 47.72% of 101/4% notes due 2015 so far
5/31/2013	BKHY	S&P rates BioScrip facilities B
5/28/2013	BKHY	Moody's upgrades BioScrip, assigns B2 ratings to loans
4/16/2013	HYLM	BioScrip intends to redeem its outstanding 101/4% senior notes
2/3/2012	BKHY	S&P affirms BioScrip at B
2/2/2012	BKHY	Moody's: BioScrip unchanged
5/4/2011	BKHY	S&P revises BioScrip to stable
4/8/2011	BKDDHY	Moody's cuts BioScrip
3/15/2011	BKHY	S&P takes BioScrip off watch
11/19/2010	BKHY	S&P: BioScrip on CreditWatch
6/7/2010	BKBWHY	BioScrip plans to reduce leverage ratio to 2-to-1 within three years
3/18/2010	HY	Market Commentary: Junk primary pauses after big session; secondary slows; funds add $597 million; Smithfield up
3/17/2010	HY	Market Commentary: Upsized QVC, Ball deals price, ILFC, SLM, BioScrip too; Blockbuster sags on Chapter 11 talk
3/17/2010	HY	New Issue: BioScrip sells $225 million 5.5-year senior notes at par to yield 101/4%
3/16/2010	HY	BioScrip talks $225 million 5.5-year senior notes to yield 101/4%-101/2%
3/16/2010	HY	Market Commentary: Upsized U.S. Steel prices, Digicel also; market awaits BioScrip; new Bombardiers keep rising
3/12/2010	HY	Market Commentary: Upsized Sirius, Huntsman price, Amsted also, Sitel sets talk; SuperValu mixed on buyout buzz
3/9/2010	HY	Market Commentary: Boise prices over-subscribed deal, MGM prices also, both firm; await Suburban Propane offering
3/9/2010	HY	BioScrip starts roadshow for $225 million 5.5-year note offering
2/26/2010	BKHY	S&P rates BioScrip loans BB-, notes B-
2/24/2010	HY	Moody's rates BioScrip notes B3
1/25/2010	BKHY	BioScrip to get $150 million loan, $225 million notes for CHS purchase

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.